Search results
Results from the WOW.Com Content Network
Mycotoxins can be found on the mold spore and mold fragments, and therefore they can also be found on the substrate upon which the mold grows. Routes of entry for these insults can include ingestion, dermal exposure, and inhalation. Aflatoxin is an example of a mycotoxin. It is a cancer-causing poison produced by certain fungi in or on foods ...
The US Centers for Disease Control and Prevention and the Environmental Protection Agency acknowledge that mold in a home can cause respiratory health problems, but say that more research is ...
Aspergillosis is caused by Aspergillus, a common mold, which tends to affect people who already have a lung disease such as cystic fibrosis or asthma, or who cannot fight infection themselves. [3] The most common causative species is Aspergillus fumigatus. [19]
The most common organ affected by aspergilloma is the lung. Aspergilloma mainly affects people with underlying cavitary lung disease such as tuberculosis, sarcoidosis, bronchiectasis, cystic fibrosis and systemic immunodeficiency. Aspergillus fumigatus, the most common causative species, is typically inhaled as small (2 to 3 micron) spores.
There are steps you can take to reduce your risk of exposure to mold spores and prevent mold from growing on foods, according to the experts and the USDA: Discard all food growing mold Do not ...
Pneumoconiosis is the general term for a class of interstitial lung disease where inhalation of dust (for example, ash dust, lead particles, pollen grains etc) has caused interstitial fibrosis. [ 1 ] [ 2 ] The three most common types are asbestosis , silicosis , and coal miner's lung . [ 3 ]
According to the Centers for Disease Control and Prevention, people with allergies, diseases that weaken the immune system, and respiratory diseases face the highest mold-related health risks.
Fungal pneumonia is an infection of the lungs by fungi. It can be caused by either endemic or opportunistic fungi or a combination of both. Case mortality in fungal pneumonias can be as high as 90% in immunocompromised patients, [1] [2] though immunocompetent patients generally respond well to anti-fungal therapy.